About BioLineRx BioLineRx Ltd. is a pre-commercial stage biopharmaceutical company pursuing life-changing therapies for certain cancers and rare diseases. The company is advancing a pipeline of investigational medicines for patients with multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., BioLineRx is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside. Learn more about who we are, what we do, and how we do it at www.biolinerx.com
View Top Employees from BioLineRxWebsite | http://www.biolinerx.com |
Ticker | BLRX |
Revenue | $12.8 million |
Funding | $90 million |
Employees | 73 (64 on RocketReach) |
Founded | 2003 |
Phone | +972 8-642-9100 |
Fax | +972 8-642-9101 |
Technologies |
JavaScript,
HTML,
Twitter
+21 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Therapeutics, Drug Development, Healthcare, Science and Engineering, Medical Device, Health Care |
Web Rank | 2 Million |
Keywords | Bioline Rx, Aetiology Of Mysthenia Gravis, Bioline Pharmaceuticals, Bl-8040, Rxbioline |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 32 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular BioLineRx employee's phone or email?
The BioLineRx annual revenue was $12.8 million in 2024.
Phil Serlin is the CEO of BioLineRx.
64 people are employed at BioLineRx.
The NAICS codes for BioLineRx are [325, 5417, 54171, 32, 541711, 541, 54].
The SIC codes for BioLineRx are [28, 283].